Contact this trialFirst, we need to learn more about you.
Farnesoid X receptor agonist
Obeticholic Acid for Barrett's Esophagus
Recruiting0 awardsPhase 2
Chapel Hill, North Carolina
This trial studies how to reduce cancer risk in people with Barrett's esophagus using obeticholic acid to reduce bile acid levels.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service